Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Peikko Australia: New, larger facilities near Brisbane, new Managing Director

Peikko has extended its commitment to the Australian market by moving to a larger facility of 2,000 m[2] located in Yatala, near Brisbane. The new premises allow Peikko to upscale its local manufacturing capability and hold greater levels of stock for its customers. Peikko is also in the process of recruiting for several new roles across Australia in order to even better meet customers’ needs and continue expanding its business and offerings to the Australian market. Furthermore, Peikko Australia has implemented a change in its leadership: effective 17 June 2021 Mr. Reuben

Life Cycle Analysis Indicates Favorable CO2 savings for Agilyx Chemical Recycling Technology

TIGARD, Oregon, USA – July 8, 2021 – Agilyx Corporation  (AGLX), a wholly owned subsidiary of Agilyx AS (Euronext Growth (Oslo): “AGLX”) and a pioneer in the chemical recycling of post-use plastics, announced today Life Cycle Analysis (LCA) results for its chemical recycling technology. Agilyx participated in the Styrenics Circular Solutions  LCA, contributing data for its depolymerization technology. During the Styrenics Circular Solutions virtual event, ‘Move to Zero. Zero Waste. Zero CO2. Powered by Styrenics, 

Kid ASA - Revenues for the Second Quarter of 2021

Lier, 8 July 2021: Kid ASA today announces unaudited revenue figures for the second quarter of 2021 (previous year in brackets). For definition of like-for-like stores, please see latest quarterly report at www.investor.kid.no.Group Q2 revenues increased by +3.9% (+22.7%) to MNOK 677.0(MNOK 651.6[1]). Like-for-like sales increased by +2.9% (+23.6%). Compared to 2019, like-for-like sales increased by +28.4%[3]. Online sales accounted for 11.3% (10.3%) of total revenues in the quarter. For the first six months of 2021, group revenues increased by +6.8% (+22.7%) to MNOK 1,246.1 (MNOK

Bambuser Joins La Maison des Startups LVMH, Growing Collaboration with World’s Largest Luxury Goods Conglomerate

Participation in accelerator program to drive innovation in Live Video Shopping solutions for LVMH and the entire luxury market Paris — 8 July 2021 — Bambuser today announced their participation in La Maison des Startups LVMH , an accelerator program created by LVMH Moët Hennessy Louis Vuitton (LVMH). As part of the multinational luxury goods conglomerate’s commitment to innovation, the program fosters collaboration between innovative startups and LVMH’s portfolio of 75 brands, known as “Maisons.” Recently named the overall winner of the 2021

Norwegian Energy Company ASA – Summons for a Written Resolution

Oslo, 8 July 2021:  Norwegian Energy Company ASA ("Noreco” or the "Company") has requested Nordic Trustee AS to dispatch a summons for a written resolution to the bondholders of NOR14 (with ISIN NO 0010870900) to make certain amendments as set out in the attached summons.  Reference is made to the Trading and Operation Update released on 28 June 2021 where the Company outlined that it intended to ask the bondholders for further leverage covenant headroom under its NOR14 senior unsecured bond agreement.   The Company and its advisors have been in close dialogue with the largest

Tezepelumab granted FDA Priority Review for asthma

8 July 2021 07:00 BST Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma Tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population across Phase II and III clinical trials AstraZeneca's Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration (FDA). Tezepelumab is being developed by AstraZeneca in collaboration with Amgen. The

Cell-type-specific insight into the function of risk factors in coronary artery disease

Using single cell technology, a new study sheds light on the significance of genetic risk factors for, and the diversity of cells involved in, the development of coronary artery disease. The researchers analysed human atherosclerotic lesions to map the chromatin accessibility of more than 7,000 cells. The chromatin accessibility is known to reflect active regions and genes in the genome. The findings were published in Circulation Research. Genome-wide association studies of the human genome have identified over 200 loci associated with coronary artery disease. More than 90% of them are

Essity joins United Nations Foundation expert group in tackling antimicrobial resistance

Hygiene and health company Essity expands its partnership with United Nations (UN) Foundation by joining a cross-industry group that brings together corporate experts in the fight against antimicrobial resistance (AMR). Essity is a global provider of hand hygiene and wound care solutions, essentials in the fight against antimicrobial resistance, one of the greatest global public health threats predicted to be responsible for 10 million annual deaths worldwide by 2050[1]. Essity has been a partner to the United Nations Foundation since 2017.AMR occurs when bacteria, viruses, fungi,

Invitation to presentation of Komplett’s second quarter 2021 results, Thursday 22 July

Oslo, 8 July 2021: Komplett ASA will report its second quarter 2021 results on Thursday, 22 July 2021.CEO Lars Olav Olaussen and CFO Krister Pedersen will present the results at 08:00 CEST.The presentation will be sent via live webcast. Please use the following link to register and view the webcast: https://events.webcast.no/viewer-registration/3kBysTKC/register. The link will also be available on https://www.komplettgroup.com/investor-relations/. Questions to the speakers can be directed using the Q&A-tool embedded in the webcast and will be addressed towards the end of the

Wallenstam’s Interim report Jan 1–Jun 30, 2021: Further strengthened balance sheet

Hans Wallenstam, CEO, and Susann Linde, CFO and Head of Investor Relations, comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CEST) at the latest. An audiocast in English with Susann Linde will take place at 09.00 (CEST) at www.financialhearings.com. The presentation is available at www.wallenstam.se/filmsandpresentations before 09.00 (CEST). January 1–June 30, 2021 · The net asset value per share increased by SEK 6.20 during the period and amounted to SEK 104.50 (98.30). · Income from property management amounted to SEK 609

Skanska rehabilitates sections of the Pulaski Skyway in Jersey City, New Jersey , USA, for USD 161M, about SEK 1.4 billion

Skanska has signed a contract with New Jersey Department of Transportation (NJDOT) to rehabilitate sections of the Pulaski Skyway in Jersey City, New Jersey, USA. The contract is worth USD 161M, about SEK 1.4 billion, which will be included in the US order bookings for the second quarter 2021.The contract includes the rehabilitation of sections of the Pulaski Skyway carrying Routes 1 and 9 in Jersey City, New Jersey, and includes the structural rehabilitation and painting of thirteen spans of the Skyway steel truss and superstructure. The contract also includes bearings replacement and pier

Betsson AB - Trading update for the second quarter 2021

· All-time high level of operating profit (EBIT) in the second quarter of 2021, estimated to be in the range of SEK 375-385 million · High sportsbook margin, high customer activity in general in combination with major sports events, such as the Copa América and the UEFA Euro 2020 and an increased share of sportsbook revenues in relation to total revenues, has created a strong EBIT momentumRevenues is expected to amount to SEK 1,735-1,755 million. Betsson has delivered its strongest quarter ever in terms of EBIT, which is higher than current consensus, fueled by a strong sportsbook

Updated results from phase 3 OCEAN study shows melflufen met primary endpoint of superior PFS – Overall Survival data lead to partial clinical hold

STOCKHOLM — July 8, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces updated results and safety measures based on the head-to-head phase 3 OCEAN study evaluating the efficacy and safety of melflufen (INN melphalan flufenamide) plus dexamethasone versus pomalidomide plus dexamethasone in patients with relapsed refractory multiple myeloma who have received 2 – 4 prior lines of therapy. The randomized study was initiated in 2017 and includes 495 patients from

Kungsleden signs new lease contracts with ABB and NKT in Alingsås

Kungsleden is extending and expanding lease contracts with ABB and NKT in the Bulten 1 property situated in Alingsås.  A new warehouse and logistics centre will be constructed to meet tenant requirements.   “It is incredibly pleasing that ABB and NKT are making investments to expand production in the property, and that we can be part of the process as a property owner and support the tenants’ operations. New jobs will also be created, which is positive for Alingsås,” says Ulrica Sjöswärd, Regional Manager, Gothenburg/Malmö at Kungsleden. Kungsleden has signed a ten-year lease

Pexip reports 41% year-on-year increase in Annual Recurring Revenue

(Oslo, Norway, July 8, 2021) In this trading update, Pexip Holding ASA (“Pexip”, Oslo Børs Ticker: PEXIP) presents its Annual Recurring Revenue (ARR) for the second quarter (Q2) of 2021. In Q2 2021, Pexip increased its ARR with 41% year-on-year to USD 92.7 million.·Pexip’s subscription base measured in ARR reached USD 92.7 million in Q2 2021, up from USD 65.8 million in Q2 2020, representing a year-on-year increase of 41%. · Of the 41% year-on-year growth in ARR, 40 percentage points (pp) are from new customers and 1 pp is from existing customers. Net revenue retention rate,

Ocean Winds and Aker Offshore Wind Announce Partnership for Floating Offshore Wind Energy in Scotland

Two of the world’s leading offshore wind energy companies have today announced their establishment of a partnership to develop floating offshore wind generation sites in Scotland.Ocean Winds and Aker Offshore Wind have formed a new partnership for the development of offshore wind in Scotland using floating technology. Currently partnering in California, USA, and Korea, the companies will join forces to bid in the ScotWind leasing round, which is making new seabed leases available for the development of offshore wind in Scottish waters.   A partnership of exponential value “Aker

PowerCell extends cooperation with ZeroAvia on hydrogen-electric aviation and secures order valued at approximately MSEK 11

PowerCell Sweden AB (publ)  has secured an order valued at a total of MSEK 10.9 from UK company ZeroAvia. The order comprises fuel cell stacks, fuel cell systems and engineering services, and is scheduled for continuous delivery over one year.The order is part of a cooperation agreement that both companies have now signed and which, within the framework of the UK HighFlyer 2 project, aims to develop a certifiable fuel cell system for commercial use in aviation. The goal of HighFlyer 2 is to develop an emissions-free 19-seat hydrogen-electric commercial aircraft. For

Attana will participate at the annual meeting for the American Society for Virology (ASV)

Attana will participate at ASV 2021 — the annual meeting for the American Society for Virology. The organization is an American scientific society serving the community of researchers within virology, the study of viruses. The virtual event takes place on July 19–23. The purpose of the Attana’s presence is to meet with potential customers and partners within virology and to present Attana Diagnostic’s newly CE-IVD-marked diagnostic kit and analytical instrument.

Norway Royal Salmon (NRS): Q2-21 Trading update

Harvested volumes for the second quarter 2021 were 9,7 thousand tonnes gutted weight, distributed to the below segments: · Farming Norway                   :  7,9 thousand tonnes gutted weight · Farming Iceland                   :  1,8 thousand tonnes gutted weight The full Q2 2021 report will be released on 23 August 2021 at 06:30 CET.   For further information, please contact: Ola Loe, CFO Mob: + 47 911 79 411  Mail: ola.loe@salmon.no   Norway Royal Salmon in brief The Norway Royal Salmon (NRS) group owns 36 085 tonnes MAB for

Notice of extraordinary general meeting of Cell Impact

The shareholders of Cell Impact AB (Nasdaq First North GM: CI B), reg. no. 556576-6655, are hereby invited to participate in an extraordinary general meeting on Monday 9 August 2021.Since the board's proposal on authorizing the board of directors to resolve upon issue of shares, warrants and/or convertibles was rejected by the annual general meeting the board has, in consultation with major shareholders, made a revised proposal for authorization of the board of directors to resolve upon issue of shares, warrants and/or convertibles and therefore convenes an extraordinary general meeting on

THE BOARD OF DIRECORS OF SCOUT GAMING GROUP ANNOUNCES THE OUTCOME OF THE DIRECTED SHARE

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, SOUTH KOREA OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR SUBJECT TO LEGAL RESTRICTIONS. PLEASE SEE IMPORTANT INFORMATION BELOW. On 1 July 2021, Scout Gaming Group AB (publ) (“Scout” or the “Company”) announced that the board of directors of the Company had resolved, pursuant to the authorization granted by the annual general meeting on 21 May

H2 Green Steel joins cross-industry CEO Alliance, to back EU plan to cut carbon emissions by 55% by 2030

· H2 Green Steel CEO Henrik Henriksson joins CEO Alliance leaders’ meeting in Paris to discuss ways to further support the EU Green Deal · The European CEO Alliance believes that fighting climate change will require a collective effort by all EU member states and collaboration between the public sector and industry · A strong carbon pricing signal on the European level is regarded as a key to achieving carbon neutrality by 2050 and cutting greenhouse gas emissions to 55% of 1990 levels by 2030 · Several cross-sector projects and policy recommendations will serve the global climate

CELLINK has initiated the process of changing name to BICO

Today, the plans for the name change from CELLINK to BICO have been announced in conjunction with the publication of the notice to the extraordinary general meeting. The new name reflects the Group's strategic bio convergence agenda and emphasizes that the company now comprises a Group consisting of several subsidiaries divided into three business areas. In addition, the journey begins to, over time, build a world-famous company by unleashing the power and future potential of a new brand. The first step in the process for changing name will be through the resolution at the Extraordinary

BEWI – Completion of acquisition of majority stake of listed Polish company IZOBLOK and completion of private placement

Reference is made to the stock exchange release dated 28 April 2021 regarding BEWI ASA's acquisition of a majority stake of the listed Polish company IZOBLOK Spólka Akcyjna, a leading European provider of Expanded Polypropylene (EPP) components to the automotive industry. The transaction was completed today. BEWI has acquired 54.21 per cent of the shares, corresponding to 65.66 per cent of the voting rights, of IZOBLOK. In connection with completion of the transaction, BEWI has also completed a private placement directed towards the majority seller in the transaction, in which 1,132,

There are no items matching the current filter
There are no more items matching the current filter
Back to top